Operational & Strategic Sourcing Analysis: Cyclobutanone (CAS No. 1191-95-3) in Active Pharmaceutical Ingredient Production

Introduction

Cyclobutanone (CAS No. 1191-95-3) is a specialized four-membered carbocyclic ketone building block (C4H6O) engineered for high-value active pharmaceutical ingredient (API) manufacturing. Defined by significant thermodynamic ring strain (~26 kcal/mol) and a highly electrophilic carbonyl center, this intermediate provides medicinal chemists and process development teams with a versatile synthon for introducing spatially constrained structural motifs into complex drug candidates.

For global pharmaceutical procurement officers, supply chain directors, and technical sourcing leads, successfully integrating Cyclobutanone into commercial manufacturing requires evaluating its synthetic utility, analytical release parameters, safe cold-chain handling, and primary supply security.

Strategic Value in Pharmaceutical Chemistry & Pipeline Design

The industrial importance of CAS No. 1191-95-3 across human health applications stems directly from its specialized molecular geometry and chemical reactivity:

Spatial Rigidification & Pharmacokinetic Optimization

Replacing conformationally flexible open-chain alkyl groups with a rigid four-membered carbocyclic ring is a proven strategy in modern medicinal chemistry to optimize key drug candidate parameters:

Target Binding Affinity:

Locking specific 3D conformations minimizes entropy penalties during receptor binding, enhancing target selectivity and potency.

Metabolic Stabilization:

The strained cyclobutane core resists rapid oxidative cleavage by liver enzymes (cytochrome P450 systems), extending systemic half-life.

Physicochemical Tuning:

Incorporating cyclobutane fragments allows chemists to fine-tune lipophilicity (log P), aqueous solubility, and blood-brain barrier permeability.

Core Therapeutic Applications

Cyclobutanone-derived building blocks are broadly deployed across several high-growth pharmaceutical pipelines:

Central Nervous System (CNS) Therapeutics:

Serving as a rigid platform for novel neurotransmitter analogues, centrally acting analgesics, and psychiatric drug candidates.

Oncology & Protease Inhibitors:

Supplying key intermediate fragments for spirocyclic and bicyclic cores in targeted cancer therapies and small-molecule enzyme inhibitors.

Antiviral & Nucleoside Chemistry:

Utilizing photochemical cycloadditions and ring-construction routes to access modified nucleoside derivatives and antiviral scaffolds.

Key Industrial Synthetic Transformations

The electrophilic carbonyl center paired with inherent ring strain enables diverse high-yielding transformations under controlled process conditions:

Nucleophilic Additions:

Reacts cleanly with organometallic reagents (e.g., Grignard, organolithium) to form sterically hindered tertiary cyclobutanols without competing side-reactions.

Reductive Amination:

Converts efficiently into primary and secondary aminocyclobutane intermediates for direct incorporation into amide or peptide-like backbones.

Ring-Expansion & Photochemical Routes:

Undergoes Baeyer-Villiger oxidations, Schmidt rearrangements, and photochemical additions to yield functionalized gamma-lactones, lactams, and spiroheterocycles that are exceptionally difficult to assemble via linear pathways.

Commercial Quality Release & Analytical Specifications

To ensure predictable performance in regulated, multi-step API manufacturing campaigns, commercial batches of Cyclobutanone must adhere to strict technical release standards:

Safe Handling, Packaging, and Logistics Stewardship

Due to its volatile liquid profile, flammable classification, and sensitivity to moisture and oxygen, Cyclobutanone requires rigorous supply chain management and storage protocols:

Inert Packaging Protocols:

Standard commercial packaging utilizes light-shielded, corrosion-resistant steel drums or specialized stainless steel ISO tanks purged with dry nitrogen gas to prevent moisture absorption and oxidative degradation.

Storage Environment:

Maintained in cool, dry, explosion-proof hazardous material facilities below 25 °C (or under refrigerated storage at 0-6 °C for extended shelf life), strictly segregated from strong bases, reducing agents, and mineral acids.

Global Transport Compliance:

Fully classified under international dangerous goods regulations (Flammable Liquid, Class 3, UN 1224, Packing Group II/III) and shipped with complete Safety Data Sheets (SDS) and lot-specific Certificates of Analysis (CoA).

Sourcing Resilience with Primary Manufacturer EASTFINE

Securing multi-ton allocations for clinical trial supply and commercial drug production requires partnering with a vetted primary producer. EASTFINE provides global pharmaceutical developers with supply security, direct technical alignment, and integrated manufacturing capabilities:

Dual-Site Infrastructure (Dalian & Heze)

Single-site dependency creates supply chain vulnerability during regional environmental inspections, routine facility turnarounds, or localized operational disruptions. EASTFINE operates two primary production facilities located in Dalian and Heze:

Operational Redundancy:

Provides continuous production capability with seamless fallback options to eliminate delivery bottlenecks and prevent project delays.

Flexible Volume Scaling:

Accommodates demand shifts from multi-kilogram pilot batches for clinical trials up to multi-ton commercial production runs.

Direct Primary Producer Value & R&D Expertise

Supported by an internal chemical research team holding 19 invention patents and 8 utility model patents, EASTFINE focuses on process route optimization, atom economy, and yield maximization. Purchasing directly from a primary producer avoids trading company markups while opening direct lines of communication with process development chemists.

Integrated Quality Systems & Regulatory Support

EASTFINE facilities operate under ISO 9001, ISO 14001, and ISO 45001 management frameworks. Every production batch undergoes full analytical verification (GC-MS, HPLC, Karl Fischer, and NMR). Complete lot traceability, archival sample retention, and comprehensive analytical documentation support global regulatory filings and customer facility audits.

Conclusion

Securing a consistent, high-purity supply of Cyclobutanone (CAS No. 1191-95-3) is critical for advancing complex small-molecule pipelines without campaign interruptions. By pairing dual-site manufacturing resilience with direct primary producer expertise, EASTFINE serves as a dependable chemical supply partner for the global life science and fine chemical industries.

Contact EASTFINE's commercial sales team to request evaluation samples, review technical dossiers, or reserve campaign volume allocations.